Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells

Oncogene volume 19, pages 4210–4220 (2000)Cite this article

Abstract

Cellular resistance to multiple proapoptotic stimuli and invasion of surrounding brain tissue by migrating tumor cells are main obstacles to an effective therapy for human malignant glioma. Here, we report that the Wnt family of embryonic differentiation genes modulate growth of malignant glioma cells in vitro and in vivo and inhibit cellular migration in vitro. sFRPs (soluble Frizzled-related proteins) are soluble proteins that bind to Wnt and interfere with Wnt signaling. We find that sFRP-1 and sFRP-2 are produced by the majority of longterm and ex vivo malignant glioma cell lines. Glioma cells that ectopically express sFRPs exhibit increased clonogenicity and enhanced resistance to serum starvation. In contrast, sFRPs do not modulate glioma cell susceptibility to apoptosis induced by the cytotoxic cytokines, CD95 (Fas/APO-1) ligand (CD95L) or Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL), or various cytotoxic drugs. sFRP-2 strongly promotes the growth of intracranial glioma xenografts in nude mice. In contrast, enhanced expression of sFRPs inhibits the motility of glioma cells in vitro. sFRP-mediated effects on glioma cells are accompanied by decreased expression and activity of matrix metalloproteinase-2 (MMP-2) and decreased tyrosine phosphorylation of β-catenin. Thus, sFRPs promote survival under non-supportive conditions and inhibit the migration of glioma cells. We suggest that the regulation of these cellular processes involves expression of MMP-2 and tyrosine phosphorylation of β-catenin. These data support a function for Wnt signaling and its modulation by sFRPs in the biology of human gliomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Amberger VR, Hensel T, Ogata N and Schwab ME. . 1998 Cancer Res. 58: 149–158.

  • Aoki M, Hecht A, Kruse U, Kemler R and Vogt PK. . 1999 Proc. Natl. Acad. Sci. USA 96: 139–144.

  • Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH and Banda MJ. . 1990 Cancer Res. 50: 2322–2329.

  • Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A and Aaronson SA. . 1999 J. Biol. Chem. 274: 16180–16187.

  • Brady-Kalnay SM, Rimm DL and Tonks NK. . 1995 J. Cell Biol. 130: 977–986.

  • Chan EF, Gat U, McNiff JM and Fuchs E. . 1999 Nat. Genet. 21: 410–413.

  • Christofori G and Semb H. . 1999 Trends. Biochem. Sci. 24: 73–76.

  • Crawford HC, Fingleton BM, Rudolph OL, Goss KJ, Rubinfeld B, Polakis P and Matrisian LM. . 1999 Oncogene 18: 2883–2891.

  • Dennis S, Aikawa M, Szeto W, d’Amore PA and Papkoff J. . 1999 J. Cell Sci. 112: 3815–3820.

  • Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA and Strongin A. . 1997 J. Cell Sci. 110: 2473–2482.

  • Dierick H and Bejsovec A. . 1999 Curr. Top. Dev. Biol. 43: 153–190.

  • Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE and Rubin JS. . 1997 Proc. Natl. Acad. Sci. USA 94: 6770–6775.

  • Friedlander DR, Zagzag D, Shiff B, Cohen H, Allen JC, Kelly PJ and Grumet M. . 1996 Cancer Res. 56: 1939–1947.

  • Garcia RG, Tallini G, Herrero A, D’Aquila TG, Carcangiu ML and Rimm DL. . 1999 Cancer Res. 59: 1811–1815.

  • Giese A and Westphal M. . 1996 Neurosurgery 39: 235–250.

  • Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z and Tetu B. . 1995 N. Engl. J. Med. 332: 839–847.

  • Hazan RB and Norton L. . 1998 J. Biol. Chem. 273: 9078–9084.

  • Hoschuetzky H, Aberle H and Kemler R. . 1994 J. Cell Biol. 127: 1375–1380.

  • Hueber A, Durka S and Weller M. . 1998 FEBS Lett. 432: 155–157.

  • Jawhari AU, Farthing MJ and Pignatelli M. . 1999 J. Pathol. 187: 155–157.

  • Kypta RM, Su H and Reichardt LF. . 1996 J. Cell Biol. 134: 1519–1529.

  • Leyns L, Bouwmeester T, Kim SH, Piccolo S and De Robertis EM. . 1997 Cell 88: 747–756.

  • Lin K, Wang S, Julius MA, Kitajewski J, Moos MJ and Luyten FP. . 1997 Proc. Natl. Acad. Sci. USA 94: 11196–11200.

  • Liu D, el Hariry I, Karayiannakis AJ, Wilding J, Chinery R, Kmiot W, McCrea PD, Gullick WJ and Pignatelli M. . 1997 Lab. Invest. 77: 557–563.

  • Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD and Umansky SR. . 1997 Proc. Natl. Acad. Sci. USA 94: 13636–13641.

  • Merzak A, Koocheckpour S and Pilkington GJ. . 1994 Cancer Res. 54: 3988–3992.

  • Miller JR, Hocking AM, Brown JD and Moon RT. . 1999 Oncogene 18: 7860–7872.

  • Müller T, Choidas A, Reichmann E and Ullrich A. . 1999 J. Biol. Chem. 274: 10173–10183.

  • Ogawa K, Yamada Y, Kishibe K, Ishizaki K and Tokusashi Y. . 1999 Cancer Res. 59: 1830–1833.

  • Paulus W and Tonn JC. . 1994 J. Neurosurg. 80: 515–519.

  • Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J and Weller M. . 2000 Biochem. Biophys. Res. Commun. 268: 607–611.

  • Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA and Nathans J. . 1997 Proc. Natl. Acad. Sci. USA 94: 2859–2863.

  • Roth W, Fontana A, Trepel M, Reed JC, Dichgans J and Weller M. . 1997 Cancer Immunol. Immunother. 44: 55–63.

  • Roth W, Wagenknecht B, Grimmel C, Dichgans J and Weller M. . 1998 Br. J. Cancer 77: 404–411.

  • Roth W, Isenmann S, Naumann U, Kügler S, Bähr M, Dichgans J, Ashkenazi A and Weller M. . 1999 Biochem. Biophys. Res. Commun. 265: 479–483.

  • Roth W and Weller M. . 1999 Cell. Mol. Life Sci. 56: 481–506.

  • Roth W, Grimmel C, Rieger L, Strik H, Takayama S, Krajewski S, Dichgans J, Reed JC and Weller M. . 2000 Brain Pathol. 10: 223–234.

  • Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M and Ito F. . 1994 Cell Adhes. Commun. 1: 295–305.

  • Tetsu O and McCormick F. . 1999 Nature 398: 422–426.

  • Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, Cumberledge S and Rubin JS. . 2000 J. Biol. Chem. 275: 4374–4382.

  • Wang S, Krinks M, Lin K, Luyten FP and Moos M. . 1997 Cell 88: 757–766.

  • Weller M, Malipiero U, Rensing-Ehl A, Barr PJ and Fontana A. . 1995 Cancer Res. 55: 2936–2944.

  • Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, Reed JC, von Deimling A and Dichgans J. . 1998 Int. J. Cancer 79: 640–644.

  • Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC and Weller M. . 1998 FEBS Lett. 440: 419–424.

  • Willert K and Nusse R. . 1998 Curr. Opin. Genet. Dev. 8: 95–102.

  • Wong MH, Rubinfeld B and Gordon JI. . 1998 J. Cell Biol. 141: 765–777.

  • Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL and Rao JS. . 1996 Cancer Res. 56: 384–392.

  • Zhou Z, Wang J, Han X, Zhou J and Linder S. . 1998 Int. J. Cancer 78: 95–99.

  • Zurawel RH, Chiappa SA, Allen C and Raffel C. . 1998 Cancer Res. 58: 896–899.

Download references

Acknowledgements

This work was supported by a grant of the Fortüne-Programm of the University of Tübingen to W Roth. The authors thank Dr W Wick for helpful discussions.

Author information

Authors and Affiliations

  1. Department of Neurology, Laboratory of Molecular Neuro-Oncology, University of Tübingen, School of Medicine, Hoppe-Seyler-Strasse 3, Tübingen, 72076 , Germany

    Wilfried Roth, Christine Wild-Bode, Michael Platten, Cornelia Grimmel, Johannes Dichgans & Michael Weller

  2. LXR Biotechnology, Inc., 1401 Marina Way South, Richmond, 94804, California, CA, USA

    Hovsep S Melkonyan

Authors
  1. Wilfried Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Wild-Bode
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Platten
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cornelia Grimmel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hovsep S Melkonyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johannes Dichgans
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Weller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roth, W., Wild-Bode, C., Platten, M. et al. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19, 4210–4220 (2000). https://doi.org/10.1038/sj.onc.1203783

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203783

Keywords

This article is cited by

Search

Advanced search

Quick links